Shilpa Holehatti Maheshwarappa

Title: Shilpa Holehatti Maheshwarappa: Innovator in Anticancer Research

Introduction

Shilpa Holehatti Maheshwarappa is a prominent inventor based in Davanagere District, India. She has made significant contributions to the field of medicinal chemistry, particularly in the development of anticancer agents. With a total of 3 patents to her name, her work is paving the way for innovative treatments in cancer therapy.

Latest Patents

Shilpa's latest patents include groundbreaking inventions such as imidazo-pyridazine derivatives that act as casein kinase 1 δ/ε inhibitors. This invention provides compounds of Formula (I) and pharmaceutically acceptable salts that inhibit protein kinase activity, making them useful as anticancer agents. Another notable patent involves substituted 4,5,6,7-tetrahydropyrazolo[1,5-A]pyrazine derivatives, which also serve as casein kinase 1 D/E inhibitors. Similar to her previous work, this invention offers compounds of Formula (I) that inhibit protein kinase activity, further contributing to the fight against cancer.

Career Highlights

Shilpa is currently employed at Bristol-Myers Squibb Company, where she continues to advance her research in the pharmaceutical industry. Her expertise in medicinal chemistry and her innovative approach to drug development have positioned her as a valuable asset in her field.

Collaborations

Throughout her career, Shilpa has collaborated with notable colleagues, including Upender Velaparthi and Mark D. Wittman. These collaborations have enhanced her research and contributed to the successful development of her patented inventions.

Conclusion

Shilpa Holehatti Maheshwarappa is a trailblazer in the field of anticancer research, with a focus on developing innovative compounds that inhibit protein kinase activity. Her contributions are significant in the ongoing battle against cancer, and her work continues to inspire future innovations in the pharmaceutical industry.